Literature DB >> 24917968

Oesophageal baseline impedance values are decreased in patients with eosinophilic oesophagitis.

Bram D van Rhijn1, Boudewijn F Kessing1, Andreas Jpm Smout1, Albert J Bredenoord1.   

Abstract

BACKGROUND: Gastro-oesophageal reflux has been suggested to play a role in eosinophilic oesophagitis (EoO). Oesophageal acid exposure decreases baseline intraluminal impedance, a marker of mucosal integrity, in patients with gastro-oesophageal reflux disease (GORD).
OBJECTIVES: The aim of this study was to assess oesophageal baseline impedance levels in EoO patients and to investigate their relationship with oesophageal acid exposure.
METHODS: Ambulatory 24-h pH-impedance monitoring was performed in 11 EoO patients and in 11 healthy controls with matched oesophageal acid exposure. We assessed baseline impedance levels in the distal, mid-, and proximal oesophageal impedance channels.
RESULTS: BASELINE IMPEDANCE LEVELS IN EOO PATIENTS WERE MARKEDLY LOWER COMPARED TO CONTROLS IN THE DISTAL OESOPHAGUS (MEDIAN (INTERQUARTILE RANGE): 988 (757-1978) vs. 2259 (1767-2896) Ω, p = 0.015), mid-oesophagus (1420 (836-2164) vs. 2614 (2374-3879) Ω, p = 0.003), and proximal oesophagus (1856 (1006-2625) vs. 2868 (2397-3439) Ω, p = 0.005). Whereas baseline impedance decreased from proximal to distal in healthy subjects (p = 0.037), no such gradient was seen in EoO patients (p = 0.123).
CONCLUSIONS: Throughout the oesophagus, baseline impedance values are decreased in EoO patients, indicating impaired mucosal integrity. Our findings suggest that factors other than acid reflux are the cause of low baseline impedance in EoO.

Entities:  

Keywords:  Aetiology; EoO; RDQ; ambulatory 24-h ph-impedance monitoring; atopy; baseline impedance; follow up; gastro-oesophageal reflux; mucosal integrity; pathophysiology

Year:  2013        PMID: 24917968      PMCID: PMC4040791          DOI: 10.1177/2050640613496411

Source DB:  PubMed          Journal:  United European Gastroenterol J        ISSN: 2050-6406            Impact factor:   4.623


  30 in total

1.  Initial validation of a diagnostic questionnaire for gastroesophageal reflux disease.

Authors:  M J Shaw; N J Talley; T J Beebe; T Rockwood; R Carlsson; S Adlis; A M Fendrick; R Jones; J Dent; P Bytzer
Journal:  Am J Gastroenterol       Date:  2001-01       Impact factor: 10.864

2.  Manometric features of eosinophilic esophagitis in esophageal pressure topography.

Authors:  S Roman; I Hirano; M A Kwiatek; N Gonsalves; J Chen; P J Kahrilas; J E Pandolfino
Journal:  Neurogastroenterol Motil       Date:  2010-11-23       Impact factor: 3.598

3.  Eosinophilic esophagitis: is it also a surgical disease?

Authors:  Francesca Rea; Tamara Caldaro; Renato Tambucci; Erminia F Romeo; Claudia Caloisi; Filippo Torroni; Giovanni Federici di Abriola; Francesca Foschia; Paola Francalanci; Luigi Dall'Oglio; Paola De Angelis
Journal:  J Pediatr Surg       Date:  2013-02       Impact factor: 2.545

4.  Coordinate interaction between IL-13 and epithelial differentiation cluster genes in eosinophilic esophagitis.

Authors:  Carine Blanchard; Emily M Stucke; Karen Burwinkel; Julie M Caldwell; Margaret H Collins; Annette Ahrens; Bridget K Buckmeier; Sean C Jameson; Allison Greenberg; Ajay Kaul; James P Franciosi; Jonathan P Kushner; Lisa J Martin; Philip E Putnam; J Pablo Abonia; Suzanne I Wells; Marc E Rothenberg
Journal:  J Immunol       Date:  2010-03-05       Impact factor: 5.422

Review 5.  The sentinel role of the airway epithelium in asthma pathogenesis.

Authors:  Stephen T Holgate
Journal:  Immunol Rev       Date:  2011-07       Impact factor: 12.988

6.  Filaggrin mutations in children with severe atopic dermatitis.

Authors:  Nilesh Morar; William O C M Cookson; John I Harper; Miriam F Moffatt
Journal:  J Invest Dermatol       Date:  2007-02-15       Impact factor: 8.551

Review 7.  Eosinophilic esophagitis: updated consensus recommendations for children and adults.

Authors:  Chris A Liacouras; Glenn T Furuta; Ikuo Hirano; Dan Atkins; Stephen E Attwood; Peter A Bonis; A Wesley Burks; Mirna Chehade; Margaret H Collins; Evan S Dellon; Ranjan Dohil; Gary W Falk; Nirmala Gonsalves; Sandeep K Gupta; David A Katzka; Alfredo J Lucendo; Jonathan E Markowitz; Richard J Noel; Robert D Odze; Philip E Putnam; Joel E Richter; Yvonne Romero; Eduardo Ruchelli; Hugh A Sampson; Alain Schoepfer; Nicholas J Shaheen; Scott H Sicherer; Stuart Spechler; Jonathan M Spergel; Alex Straumann; Barry K Wershil; Marc E Rothenberg; Seema S Aceves
Journal:  J Allergy Clin Immunol       Date:  2011-04-07       Impact factor: 10.793

8.  An analysis of distal esophageal impedance in individuals with and without esophageal motility abnormalities.

Authors:  Wojciech Blonski; Amine Hila; Marcelo F Vela; Donald O Castell
Journal:  J Clin Gastroenterol       Date:  2008-08       Impact factor: 3.062

Review 9.  Thoughts on the complex relationship between gastroesophageal reflux disease and eosinophilic esophagitis.

Authors:  Stuart Jon Spechler; Robert M Genta; Rhonda F Souza
Journal:  Am J Gastroenterol       Date:  2007-06       Impact factor: 10.864

10.  Omeprazole blocks STAT6 binding to the eotaxin-3 promoter in eosinophilic esophagitis cells.

Authors:  Xi Zhang; Edaire Cheng; Xiaofang Huo; Chunhua Yu; Qiuyang Zhang; Thai H Pham; David H Wang; Stuart J Spechler; Rhonda F Souza
Journal:  PLoS One       Date:  2012-11-21       Impact factor: 3.240

View more
  7 in total

1.  Presence of intraepithelial food antigen in patients with active eosinophilic oesophagitis.

Authors:  E V Marietta; D M Geno; T C Smyrk; A Becker; J A Alexander; M Camilleri; J A Murray; D A Katzka
Journal:  Aliment Pharmacol Ther       Date:  2016-11-22       Impact factor: 8.171

Review 2.  Recent Advances in Non-invasive Esophageal Tissue Sampling.

Authors:  David A Katzka
Journal:  Curr Gastroenterol Rep       Date:  2017-03

Review 3.  Recent discoveries and emerging therapeutics in eosinophilic esophagitis.

Authors:  Aakash Goyal; Edaire Cheng
Journal:  World J Gastrointest Pharmacol Ther       Date:  2016-02-06

4.  Translating new developments in eosinophilic esophagitis pathogenesis into clinical practice.

Authors:  Edaire Cheng
Journal:  Curr Treat Options Gastroenterol       Date:  2015-03

5.  Histological Response to Fluticasone Propionate in Patients With Eosinophilic Esophagitis Is Associated With Improved Functional Esophageal Mucosal Integrity.

Authors:  Bram D van Rhijn; Joanne Verheij; Marius A van den Bergh Weerman; Caroline Verseijden; René M J G J van den Wijngaard; Wouter J de Jonge; Andreas J P M Smout; Albert J Bredenoord
Journal:  Am J Gastroenterol       Date:  2015-08-25       Impact factor: 10.864

6.  TGF-β1 alters esophageal epithelial barrier function by attenuation of claudin-7 in eosinophilic esophagitis.

Authors:  N Nguyen; S D Fernando; K A Biette; J A Hammer; K E Capocelli; D A Kitzenberg; L E Glover; S P Colgan; G T Furuta; J C Masterson
Journal:  Mucosal Immunol       Date:  2017-08-23       Impact factor: 7.313

Review 7.  Eosinophilic Esophagitis Is an Underlying Cause for Gastrointestinal Concerns in Children.

Authors:  Kunsong Lee; Glenn T Furuta; Nathalie Nguyen
Journal:  Front Pediatr       Date:  2018-05-03       Impact factor: 3.418

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.